In a recent webinar, Dalia Rosano Imperial College London) discussed breast cancer and epigenetic combination therapies.

A nurse practitioner discussed considerations for managing aromatase inhibitor-related joint pain in patients with breast ...

Three different treatment strategies are currently under investigation to determine how to optimally improve upon tamoxifen: an aromatase inhibitor as a replacement for 5 years of tamoxifen (early ...

New evidence shows that extended estrogen suppression treatment using aromatase inhibitors for hormone receptor-positive postmenopausal breast cancer is safe; it does not increase the risk of ...

I have been on an aromatase inhibitor for the past eight months and have side effects that keep me from having a good quality of life. I am supposed to be on it for five years, but I do not want to ...

Researchers found that 44.8% of the 357 patients exhibited coronary artery calcium; groups had no significant difference in aromatase inhibitor treatment duration. HealthDay News — For ...

Hormonal therapy, particularly the use of aromatase inhibitors (which block the production of estrogen), is a standard treatment after breast cancer surgery for postmenopausal women.

Patients, pathologists, clinicians, researchers, radiologists and others from around the world recently gathered for the 2024 ...

For patients with hormone receptor (HR)-positive, HER2-negative early breast cancer, the combination of Kisqali (ribociclib) and nonsteroidal aromatase inhibitor (NSAI) therapy resulted in sustained ...

The statistics are frightening. Lung cancer is the leading cancer killer in the U.S., but each year many more women are given ...

Hormonal therapy, particularly the use of aromatase inhibitors (which block the production of estrogen), is a standard treatment after breast cancer surgery for postmenopausal women. While these ...

N ew evidence shows that extended estrogen suppression treatment using an aromatase inhibitors for hormone receptor-positive ...